A Phase I study of the novel immunomodulatory agent PG545 (pixatimod) in subjects with advanced solid tumours

- Dredge, Keith, Brennan, Todd V., Millward, Michael, Hammond, Edward, Lickliter, Jason D., Liwen, Lin, Bampton, Darryn, Handley, Paul, Lankesheer, Fleur, Morrish, Glynn, Yang, Yiping

Immunomodulatory activities of pixatimod: Emerging nonclinical and clinical data, and its potential utility in combination with PD-1 inhibitors

- Hammond, Edward, Haynes, Nicole M., Cullinane, Carleen, Brennan, Todd V., Bampton, Darryn, Handley, Paul, Karoli, Tomislav, Lanksheer, Fleur, Lin, Liwen, Yang, Yiping, Dredge, Keith